Inovalon Stock Forecast, Price & News

Inovalon's stock was trading at $17.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, INOV stock has increased by 9.6% and is now trading at $19.02.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Inovalon.

Wall Street analysts have given Inovalon a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Inovalon wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Inovalon.

Inovalon Holdings, Inc. (NASDAQ:INOV) announced its quarterly earnings results on Wednesday, October, 28th. The technology company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.04. The technology company had revenue of $161.38 million for the quarter, compared to analysts' expectations of $179.27 million. Inovalon had a net margin of 0.87% and a return on equity of 9.07%.
View Inovalon's earnings history.

Inovalon issued an update on its FY21 earnings guidance on Wednesday, October, 28th. The company provided earnings per share (EPS) guidance of $0.73 to $0.75 for the period, compared to the Thomson Reuters consensus estimate of $0.63. The company issued revenue guidance of $741 million to $768 million, compared to the consensus revenue estimate of $759.67 million.

8 brokerages have issued twelve-month target prices for Inovalon's shares. Their forecasts range from $15.00 to $29.00. On average, they anticipate Inovalon's share price to reach $23.63 in the next twelve months. This suggests a possible upside of 24.2% from the stock's current price.
View analysts' price targets for Inovalon.

Some companies that are related to Inovalon include Pegasystems (PEGA), Five9 (FIVN), Zynga (ZNGA), JOYY (YY), Globant (GLOB), CoreLogic (CLGX), DXC Technology (DXC), Proofpoint (PFPT), Change Healthcare (CHNG), Upwork (UPWK), LiveRamp (RAMP), Perspecta (PRSP), CarGurus (CARG), EVERTEC (EVTC) and Liberty TripAdvisor (LTRPB).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Square (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH).

(INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

Inovalon's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.91%), Black Creek Investment Management Inc. (1.89%), Neuberger Berman Group LLC (1.44%), Bernzott Capital Advisors (1.33%), State Street Corp (0.95%) and Riverbridge Partners LLC (0.94%). Company insiders that own Inovalon stock include Bock Peter De, Jason Capitel, Jonathan R Boldt, Keith R Dunleavy, Robert A Wychulis and William J Teuber Jr.
View institutional ownership trends for Inovalon.

INOV stock was sold by a variety of institutional investors in the last quarter, including Black Creek Investment Management Inc., Cowen Prime Services LLC, Neuberger Berman Group LLC, Arrowstreet Capital Limited Partnership, BlackRock Inc., Iron Triangle Partners LP, Riverbridge Partners LLC, and Charles Schwab Investment Management Inc.. Company insiders that have sold Inovalon company stock in the last year include Jason Capitel, Jonathan R Boldt, and Robert A Wychulis.
View insider buying and selling activity for Inovalon.

INOV stock was purchased by a variety of institutional investors in the last quarter, including Bernzott Capital Advisors, Spence Asset Management, Castleark Management LLC, Federated Hermes Inc., Mackay Shields LLC, Oberweis Asset Management Inc., SG Americas Securities LLC, and GSA Capital Partners LLP. Company insiders that have bought Inovalon stock in the last two years include Bock Peter De, Keith R Dunleavy, and William J Teuber Jr.
View insider buying and selling activity for Inovalon.

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of INOV stock can currently be purchased for approximately $19.02.

Inovalon has a market capitalization of $2.96 billion and generates $642.41 million in revenue each year. The technology company earns $7.78 million in net income (profit) each year or $0.41 on an earnings per share basis. Inovalon employs 2,662 workers across the globe.

The official website for Inovalon is www.inovalon.com.

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]